Ghent University Academic Bibliography

Miscellaneous

A remarkable presentation of a massive Budd-Chiari syndrome

Kymentie Ferdinande (UGent) , Helena Degroote (UGent) , Anja Geerts (UGent) , Hans Van Vlierberghe (UGent) , Xavier Verhelst (UGent) and Sarah Raevens (UGent)

(2023) ACTA GASTRO-ENTEROLOGICA BELGICA. 86(3). p.503-504

Add to list

Journal Article
A1
open access

Local control of hepatocellular carcinoma and colorectal liver metastases after surgical microwave ablation without concomitant hepatectomy

Luis Filipe Abreu de Carvalho, Bram Logghe (UGent) , Stijn Van Cleven (UGent) , Aude Vanlander, Suzane Moura Ribeiro (UGent) , Karen Geboes (UGent) , Clarisse Lecluyse (UGent) , Peter Smeets (UGent) , Helena Degroote (UGent) , Hans Van Vlierberghe (UGent) , et al.

(2021) LANGENBECKS ARCHIVES OF SURGERY.

Add to list

Journal Article
A1
open access

Risk of hepatocellular carcinoma in hepatitis B and D virus co-infected patients : a systematic review and meta-analysis of longitudinal studies

Habiba Kamal, Romina Fornes, Johanna Simin, Per Stal, Ann-Sofi Duberg, Nele Brusselaers (UGent) and Soo Aleman

(2021) JOURNAL OF VIRAL HEPATITIS. 28(10). p.1431-1442

Add to list

Angiogenesis in the progression of non-alcoholic fatty liver disease

Sander Lefere (UGent) , Lindsey Devisscher (UGent) and Anja Geerts (UGent)

(2020) ACTA GASTRO-ENTEROLOGICA BELGICA. 83(2). p.301-307

Add to list

Start-up conflict and hair cortisol

Gosia Kozusznik (UGent) and Martin C. Euwema

(2020) PSYCHONEUROENDOCRINOLOGY. 119.

Add to list

Bariatric surgery patients are at risk for alcoholic liver disease with need for liver transplantation

Sander Lefere (UGent) , Lenka Stroobant (UGent) , Xavier Verhelst (UGent) , Aude Vanlander, Frederik Berrevoet (UGent) , Roberto Troisi (UGent) , Yves Van Nieuwenhove (UGent) , Xavier Rogiers (UGent) , Hans Van Vlierberghe (UGent) and Anja Geerts (UGent)

(2020) OBESITY SURGERY. 30(11). p.4659-4664

Add to list

Combined analysis of metabolomes, proteomes, and transcriptomes of hepatitis C virus-infected cells and liver to identify pathways associated with disease development

Joachim Lupberger, Tom Croonenborghs, Armando Andres Roca Suarez, Nicolaas Van Renne, Frank Jühling, Marine A Oudot, Alessia Virzì, Simonetta Bandiera, Carole Jamey, Gergö Meszaros, et al.

(2019) GASTROENTEROLOGY. 157(2). p.537-551

Add to list

Journal Article
A1
open access

Exposure assessment and risk characterization of aflatoxin M1 intake through consumption of milk and yoghurt by student population in Serbia and Greece

Bozidar Udovicki, Ilija Djekic, Eleni P. Kalogianni and Andreja Rajkovic (UGent)

(2019) TOXINS. 11(4).

Add to list

Journal Article
A1
open access

Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib

Lorenza Rimassa, Giovanni Abbadessa, Nicola Personeni, Camillo Porta, Ivan Borbath, Bruno Daniele, Stefania Salvagni, Jean-Luc Van Laethem, Hans Van Vlierberghe (UGent) , Jörg Trojan, et al.

(2016) ONCOTARGET. 7(45). p.72622-72633

Academic Bibliography

A remarkable presentation of a massive Budd-Chiari syndrome

Local control of hepatocellular carcinoma and colorectal liver metastases after surgical microwave ablation without concomitant hepatectomy

Risk of hepatocellular carcinoma in hepatitis B and D virus co-infected patients : a systematic review and meta-analysis of longitudinal studies

Angiogenesis in the progression of non-alcoholic fatty liver disease

Start-up conflict and hair cortisol

Bariatric surgery patients are at risk for alcoholic liver disease with need for liver transplantation

Combined analysis of metabolomes, proteomes, and transcriptomes of hepatitis C virus-infected cells and liver to identify pathways associated with disease development

Exposure assessment and risk characterization of aflatoxin M1 intake through consumption of milk and yoghurt by student population in Serbia and Greece

Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib

Contents

Support

Contact